Metabolic Dysfunction–Associated Fatty Liver Disease Increases Colon Cancer Risk: A Nationwide Cohort Study
Open Access
- 1 January 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 13 (1) , e00435
Abstract
INTRODUCTION: The association between nonalcoholic fatty liver disease (NAFLD) and colorectal cancer (CRC) has been controversial. Using the new consensus-driven definition, we evaluated the association of metabolic dysfunction–associated fatty liver disease (MAFLD) with the risk of developing CRC. METHODS: From a nationwide health screening database, we included 8,933,017 participants (48.6% male) aged 40–64 years between 2009 and 2010. Participants were categorized by the presence of fatty liver disease (FLD)—NAFLD and MAFLD, separately—and by the combination of the 2 definitions: neither FLD, NAFLD only, MAFLD only, or both FLD. The primary outcome was the development of CRC. RESULTS: Among the participants, 2,517,330 (28.2%) had NAFLD, and 3,337,122 (37.4%) had MAFLD, whereas 2,465,151 (27.6%) met both NAFLD and MAFLD definitions. Over a median follow-up period of 10.1 years, 60,888 new CRC cases developed. NAFLD and MAFLD were each associated with a significantly higher risk of developing CRC. When the neither FLD group was the reference, multivariable-adjusted hazard ratios (95% confidence interval) for CRC were 1.16 (1.06–1.28) in the NAFLD only group, 1.18 (1.16–1.20) in the both FLD group, and 1.32 (1.28–1.35) in the MAFLD only group. The presence of advanced liver fibrosis further increased CRC risk in each FLD group. DISCUSSION: FLD was associated with a higher risk of CRC development. CRC risk was higher in the presence of MAFLD, especially when accompanied by liver fibrosis.Keywords
This publication has 40 references indexed in Scilit:
- Nonalcoholic Fatty Liver DiseaseMedicine, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Non–Laboratory-Based Self-Assessment Screening Score for Non-Alcoholic Fatty Liver Disease: Development, Validation and Comparison with Other ScoresPLOS ONE, 2014
- Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large studyMolecular Biology Reports, 2014
- Colorectal neoplasms in relation to non‐alcoholic fatty liver disease in Korean women: A retrospective cohort studyJournal of Gastroenterology and Hepatology, 2011
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 CountriesAmerican Journal of Epidemiology, 2011
- Prevalence and risk of colorectal neoplasms in asymptomatic, average-risk screenees 40 to 49 years of ageGastrointestinal Endoscopy, 2010
- Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort StudyAmerican Journal of Gastroenterology, 2010
- Association of Metabolic Syndrome With Proximal and Synchronous Colorectal NeoplasmClinical Gastroenterology and Hepatology, 2007
- Metabolic and Adipokine Profile of Chinese Patients With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2006